Actively Recruiting
Effect of Guided Imagery on Chemotherapy-related Nausea and Vomiting
Led by Baskent University · Updated on 2026-05-01
40
Participants Needed
1
Research Sites
155 weeks
Total Duration
On this page
Sponsors
B
Baskent University
Lead Sponsor
H
Hacettepe University
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this randomized controlled study is to assess the effect of guided imagery on chemotherapy-related nausea and vomiting in pediatric oncology patients. Participants will receive either guided imagery+routine care or routine care. The researchers will compare nausea and vomiting and vital signs between groups.
CONDITIONS
Official Title
Effect of Guided Imagery on Chemotherapy-related Nausea and Vomiting
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 7 to 18 years
- Scheduled to receive intravenous chemotherapy
- No cognitive or neurological diseases preventing communication
- Receiving chemotherapy with moderate or high nausea risk per MASCC/ESMO guidelines
- Able to communicate verbally, visually, and auditorily in Turkish with no mental deficiency
- Participant and parent voluntarily agree to participate
You will not qualify if you...
- Currently receiving radiotherapy
- Taking ginger powder or vitamins to reduce nausea
- Does not wish to participate in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hacettepe University İhsan Doğramacı Hospital
Ankara, Ankara, Turkey (Türkiye), 06100
Actively Recruiting
Research Team
A
Ayşe Ay, RN, PhD
CONTACT
Y
Yağmur Sezer Efe, RN, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here